What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)?

What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)?

What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)?

0% Complete

Course Overview

NA

Course Content

What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)?

Course Details

Duration: 0.00 hour
Released: May 14, 2025
Last Review: May 14, 2025
Expires: May 14, 2028

Objectives

NA

Target Audience

NA

Faculty & Disclosure

Faculty

Ticiana Leal, MD

Disclosure

Ticiana Leal, MD discloses no such relationships exist

Accreditation

NA

Related Courses

2026 MCM | Dealing with Long Term Effects of Breast Cancer Immunotherapy and Targeted Therapy

2026 MCM | Dealing with Long Term Effects of Breast Cancer Immunotherapy and Targeted Therapy

0.00 AMA PRA Category 1 Credits™

2026 MCM | Integrative Medicine and Cancer: How to Improve the Quality of Life and Well Being of Our Patients and Survivors

2026 MCM | Integrative Medicine and Cancer: How to Improve the Quality of Life and Well Being of Our Patients and Survivors

0.00 AMA PRA Category 1 Credits™

Explore More Courses